Literature DB >> 21371196

Identification of factor VIII gene mutations in patients with severe haemophilia A in Venezuela: identification of seven novel mutations.

S Albánez1, A Ruiz-Sáez, A Boadas, N de Bosch, A Porco.   

Abstract

Haemophilia A is caused by mutations in the gene encoding coagulation factor VIII (FVIII). In severe Haemophilia A (sHA), two inversions are responsible for approximately 50% of the genetic alterations (intron 22 and intron 1 inversions). The other mutations are extremely diverse and each affected family generally has its own mutation. Our aim was to detect the genetic alterations present in the FVIII gene (F8) in 54 unrelated male patients with sHA in Venezuela. We initially detected the presence of the intron 22 inversion by performing inverse PCR, and the negative patients for this inversion were analysed for the intron 1 inversion by PCR. Patients negative for both inversions were analysed using Conformation Sensitive Gel Electrophoresis for mutations in all exons, promoter region and 3'-UTR. sHA causative mutations were identified in 49 patients. Intron-22 and -1 inversions were detected in 41% and 0% of patients respectively. Besides these two mutations, 25 different mutations were identified, including nine nonsense, four small deletions, two small insertions, four missense, three splicing mutations and three large deletions. Seven novel mutations were identified, including two nonsense mutations, two small deletions, one small insertion, one missense mutation and one splicing mutation. Thirty one percent of the patients with identified mutations developed inhibitors against exogenous FVIII. This is the first report of F8 mutations in patients with sHA in Venezuela; the data from this study suggests that the spectrum of gene defects found in these patients is as heterogeneous as reported previously for other populations.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21371196     DOI: 10.1111/j.1365-2516.2011.02500.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  5 in total

1.  Genetic Characterization of the Factor VIII Gene in a Cohort of Colombian Patients with Severe Hemophilia A with Inhibitors.

Authors:  Samuel Sarmiento Doncel; Gina Alejandra Diaz Mosquera; Ronald Guillermo Pelaez; Javier Mauricio Cortes; Carol Agudelo Rico; Francisco Javier Meza Cadavid; Nelson Ramirez Plazas; Ivan Alfredo Perdomo Amar; Jorge Enrique Peña Siado; Fabian Andres Parrado Rey; Cesar Alberto Montaño; Alexys Maza Villadiego
Journal:  Hematol Rep       Date:  2022-05-04

2.  In silico profiling of deleterious amino acid substitutions of potential pathological importance in haemophlia A and haemophlia B.

Authors:  George Priya Doss C
Journal:  J Biomed Sci       Date:  2012-03-16       Impact factor: 8.410

3.  Factor 8 Gene Mutation Spectrum of 270 Patients with Hemophilia A: Identification of 36 Novel Mutations

Authors:  Tahir Atik; Esra Işık; Hüseyin Onay; Bilçağ Akgün; Moharram Shamsali; Kaan Kavaklı; Melike Evim; Gülen Tüysüz; Namık Yaşar Özbek; Fahri Şahin; Zafer Salcıoğlu; Canan Albayrak; Yeşim Oymak; Ekrem Ünal; Fatma Burcu Belen; Ebru Yılmaz Keskin; Can Balkan; Birol Baytan; Alphan Küpesiz; Vildan Culha; Tuba Nur Tahtakesen Güçer; Adalet Meral Güneş; Ferda Özkınay
Journal:  Turk J Haematol       Date:  2020-02-06       Impact factor: 1.831

Review 4.  Importance of immune response genes in hemophilia A.

Authors:  Josiane Bazzo de Alencar; Luciana Conci Macedo; Morgana Ferreira de Barros; Camila Rodrigues; Renata Campos Cadide; Ana Maria Sell; Jeane Eliete Laguila Visentainer
Journal:  Rev Bras Hematol Hemoter       Date:  2013

5.  Mutation analysis in the F8 gene in 485 families with haemophilia A and prenatal diagnosis in China.

Authors:  Yin Feng; Qianqian Li; Panlai Shi; Ning Liu; Xiangdong Kong; Ruixia Guo
Journal:  Haemophilia       Date:  2020-11-27       Impact factor: 4.287

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.